Immunogenicity of SARSCoV2 Third Dose Vaccine Strategies in Immunocompromised Patients with Suboptimal Immunity Following Two Doses (OCTAVE-DUO): an Open-Label, Multi-Centre, Randomised, Controlled Phase III Trial Carl S. Goodyear , Amit Patel , Eleanor Barnes , Michelle Willicombe , Stefan Siebert , Thushan I. de Silva , John A. Snowden , Sean Lim , Sarah Bowden , Lucinda J. Billingham , Alex G. Richter , Miles W. Carroll , Edward J. Carr , Rupert Beale , Daniel Rea , Helen Parry , Sarah Pirrie , Zixiang Lim , Jack Satsangi , Susanna Dunachie , Gordon Cook , Paul Miller , Neil Basu , Ashley Gilmour , Anne-Marie Hodgkins , Lili Evans , Ana Hughes , Stephanie Longet , Georgina Meacham , Kwee Yong , Matthew Ahearne , Mickey B. C. Koh , Siobhan O. Burns , Kim Orchard , Caron Paterson , Graham McIlroy , Sam M. Murray , Tina Thomson , Stavros Dimitriadis , Lyndsey Goulston , Samantha Miller , Victoria Keillor , Maria Prendecki , David Thomas , Amanda Kirkham , Iain McInnes , Pamela Kearns openalex（2023）
Key words
Immunity, Vaccines
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
